- Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple Sclerosis2021 | First Faculty of Medicine
- Supportive strategies to improve adherence to IFN beta-1b in Multiple Sclerosis - Results of the BetaPlus observational cohort study2011 | Second Faculty of Medicine
- Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension2018 | First Faculty of Medicine
- Depresion and Multiple Sclerosis2003 | First Faculty of Medicine
- Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study2008 | Second Faculty of Medicine